Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Primary Care
•
General Primary Care
•
Women
How do you approach the risk/benefit discussion with patients when you are considering starting menopausal HRT?
Particularly in low risk patient in regards to typical ASE of HRT.
Related Questions
Do you start bisphosphonates after tapering off menopausal hormone therapy to prevent the rapid decline of bone mineral density?
What symptom or constellation of symptoms are most specific for endometriosis that should prompt further workup?
How do you decide whether average-risk patients should undergo annual or biennial breast cancer screening?
What strategies do you recommend for discussing the use of OCP in women with a history of migraines with or without aura?
How has the use of CGMs informed or improved your management of patients with pre diabetes or diabetes not on insulin?
What treatment / management strategies do you find helpful for cannabis use disorder?
How do you approach patients either requesting to have you order or have obtained multi-cancer early detection panels from another provider? Does your recommendation change in those who are high risk (by personal risk factors or family history)?
How do you counsel patients on GLP-1 agonists for weight loss who wish to space out their medication or take a "drug holiday" to temporarily increase their appetite?
What patient factors most strongly influence your decision to start biologic agents in mild cognitive impairment?
Is there an age cutoff where you consider the risks of monoclonal antibody therapy outweigh any potential benefit(s) in early-onset dementia?